Inicio › Cáncer de esófago › Nueva York

Ensayos clínicos de Cáncer de esófago en Nueva York

28 estudios sobre Cáncer de esófago buscan participantes en Nueva York.

Ciudades en Nueva York

Texto oficial del estudio (inglés)

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
Icahn School of Medicine at Mount Sinai, New York
y 2 más

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06465069

A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

Hematology-Oncology Associates of Central NY, P.C. ( Site 4925), East Syracuse

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT05319730

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Montefiore Medical Center-Einstein Campus, The Bronx
James J Peters VA Medical Center, The Bronx

ReclutandoSe aceptan voluntarios sanos

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT07283939

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Stony Brook University Medical Center, Stony Brook

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 a 75 · Todos los sexos · Actualizado el 2 oct 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Roswell Park Cancer Institute IDS, Buffalo
Memorial Sloan Kettering Hospital, New York

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT06172478

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
y 1 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT06123338

Pan-tumor MRD Study

Guthrie Lourdes Memorial Hospital (GLMH), Binghamton
New York Cancer & Blood Specialists, Shirley

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT06605404

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

New York University (NYU) Langone Medical Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

New York University (NYU) Clinical Cancer Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07213791

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Columbia University, New York
NYU Langone Health, New York
Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06128551

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Memorial Sloan Kettering Cancer Center Head Neck Services, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT05983432

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

Icahn School of Medicine at Mount Sinai, New York
Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07217704

A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma

Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
y 1 más

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT07818018

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

NYU Langone Hospital - Long Island Investigational Pharmacy, Mineola
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 sept 2026 · NCT06293898

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Research Site, New York
Research Site, New York
Research Site, New York
y 2 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT07431281

Retrospective Review of Esophageal Cancer at MSKCC

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT05706558

Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)

Hematology-Oncology Associates of Central NY, P.C. ( Site 8925), East Syracuse

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT06445972

Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

Hematology-Oncology Associates of Central NY, P.C. ( Site 6925), East Syracuse

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT06469944

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 27 ago 2026 · NCT07227168

Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

Columbia University Medical Center, New York

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 ago 2026 · NCT00288119

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Cayuga Medical Center, Ithaca
Mt. Sinai, New York
Memorial Sloan Kettering Cancer Center, New York
y 1 más

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 jul 2026 · NCT03526835

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 jul 2026 · NCT06695845

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon
North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Brooklyn
North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park
y 7 más

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 6 jul 2026 · NCT04389632

Integrated Cancer Repository for Cancer Research

C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
Faxton St. Luke's Healthcare, Mohawk Valley, Utica

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 19 a 110 · Todos los sexos · Actualizado el 29 jun 2026 · NCT02012699

Registry for Esophageal and Gastroesophageal Junction Cancer

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 may 2026 · NCT06558786

Brodalumab in the Treatment of Immune-Related Adverse Events

Columbia University Irving Medical Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 may 2026 · NCT06673329

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Weill Cornell Medicine, Cornell University (site 126), New York

ReclutandoFase 1/2

Edades de 18 a 80 · Todos los sexos · Actualizado el 11 dic 2025 · NCT03556228

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Buffalo
Massive Bio SYNERGY-AI site, Hempstead
Massive Bio SYNERGY-AI site, Manhasset
y 2 más

ReclutandoEstudio observacional

Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774

De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.